Stocks and InvestingStocks and Investing
Wed, July 6, 2022
Tue, July 5, 2022
Mon, July 4, 2022
Sun, July 3, 2022
Fri, July 1, 2022
Thu, June 30, 2022

Andrew Fein Initiated (ABOS) at Strong Buy and Held Target at $15 on, Jun 30th, 2022


Published on 2024-10-27 21:43:09 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Jun 30th, 2022.

Andrew has made no other calls on ABOS in the last 4 months.



There is 1 other peer that has a rating on ABOS. Out of the 1 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $17 on, Tuesday, March 29th, 2022